Fexuprazan not checked

Daewoong Pharmaceutical Co. LTD. · DWP14012

FollowEvery change as it happens, and a Monday email
Stage
in other
Next date
Phase 4 trial completes
Trials
3 active
16 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“Fexuprazan 20mg placebo-matching tablet, orally, once daily for up to 24 weeks”In the company’s words, NCT07533266 on ClinicalTrials.gov
Tested for
NSAID (Non-Steroidal Anti-Inflammatory Drug), Gastric Ulcer, Healed Erosive Esophagitis
Main trialPhase 4
“The study aims to demonstrate the preventive effect of Fexuprazan 20 mg for peptic ulcer is non-inferior to that of Lansoprazole 15 mg in terms of prevention of peptic ulcer and confirm the safety of Fexuprazan 20 mg.”In the company’s words, NCT07533266 on ClinicalTrials.gov
Other names
DWP14012 · Fexuclue

Other drugs for Gastric Ulcer

All 2 drugs for Gastric Ulcer

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials16

TrialPhaseCompletesWhat it tests
Phase 4Not yet recruiting Dec 2027 Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer
Phase 3Not yet recruiting 15 Apr 2028 Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer
Phase 3Not yet recruiting Aug 2029 Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed Erosive Esophagitis
Phase 3Completed 4 Aug 2021 Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis
Phase 3Completed 23 Jul 2022 The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis
Phase 3Completed 27 Nov 2023 Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer
Phase 3Unknown Jan 2025 Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)
Phase 3Completed 24 Apr 2025 Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori
Phase 1Unknown 30 Jun 2021 Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers
Phase 1Completed 26 Oct 2021 Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects
Phase 1Completed 29 Mar 2022 Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers
Phase 1Completed 22 May 2022 Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects
Phase 1Completed 6 Mar 2023 Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects
Phase 1Unknown 28 Mar 2023 Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects
Phase 1Unknown 31 May 2023 A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects
Phase 1Unknown Jan 2025 to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Fexuprazan

Following is part of Solo: you see every change to Fexuprazan the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in